Location History:
- Spotsylvania, VA (US) (2014 - 2017)
- Williamsburg, VA (US) (2010 - 2019)
Company Filing History:
9 out of 402 
1 out of 216 
Years Active: 2010-2019
Title: The Innovative Contributions of Christopher G. Earnhart
Introduction
Christopher G. Earnhart, based in Spotsylvania, VA, is an accomplished inventor with a strong focus on advancements in Lyme disease diagnostics and therapies. With a total of 9 patents to his name, Earnhart's innovative work is making significant contributions to the field of veterinary and human medicine.
Latest Patents
Among his patent portfolio, two major inventions stand out. The first is the "Polyvalent chimeric OspC vaccinogen and diagnostic antigen." This invention includes chimeric polyvalent recombinant proteins aimed at developing effective vaccines and diagnostics for Lyme disease in both canines and humans. These chimeric proteins utilize specific epitopes from the loop 5 region and alpha helix 5 region of outer surface protein C (OspC) and OspE types, enhancing their efficacy in addressing mammalian infections.
The second significant patent is the "Lyme disease vaccine," which comprises antigenic polypeptides formulated with linear immunodominant epitopes of outer surface protein A (OspA) and outer surface protein C (OspC). These polypeptides are particularly valuable for vaccine development and diagnostics in detecting infections, as they represent a range of peptides from multiple distinct phyletic groups, incorporating epitopes from both OspA and OspC.
Career Highlights
Christopher Earnhart's professional journey includes notable stints at Virginia Commonwealth University and Zoetis Services LLC, where he honed his skills in research and innovation. His dedication to advancing science in the realm of infectious diseases has established him as a respected figure in the medical and veterinary communities.
Collaborations
Throughout his career, Earnhart has collaborated with prominent experts in his field, including Richard Thomas Marconi and Robert M. Lohse. Their combined expertise has undoubtedly enriched his research outcomes and broadened the impact of his inventions.
Conclusion
Christopher G. Earnhart exemplifies the spirit of innovation in the ongoing battle against Lyme disease. His patents underscore a commitment to improving diagnostic and therapeutic options, benefiting both humans and animals. As he continues to explore new horizons in medical technology, his work remains a beacon of hope in the fight against infectious diseases.